Company-wide revenue
Reported revenue in 2020 ¥17.19B Reported revenue in 2024 ¥29.97B
- growth amount
- +¥12.78B
- growth annualized
- +14.9%
- growth total
- +74.3%
Japanese company profile · 7730
MANI, INC.
In its FY2024 public filing, MANI, INC. reports Surgical products, Iris needle products, Dental products. The page shows business-level revenue and profit where the source disclosures support comparison.
Original Japanese company name: マニー株式会社
English company name recorded in Japan's EDINET filer data. English company name source
Reported company-wide figures
What does this company do?
What does this company do?
MANI, INC.'s largest reported business by revenue in FY2024 was Iris needle products.
The business with the highest reported segment profit in FY2024 was Iris needle products.
FY2024 · fiscal year ended August 2025 View original filing ↗ The source document may be in Japanese.
Business structure
How does it make money?
| Business | Sales | Revenue share | Operating profit |
|---|---|---|---|
| Iris needle products | ¥11.18B ↗ | 37.3% | ¥4B ↗ |
| Dental products | ¥9.51B ↗ | 31.7% | ¥1.11B ↗ |
| Surgical products | ¥9.27B ↗ | 30.9% | ¥3.08B ↗ |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2024 · fiscal year ended August 2025. Revenue and profit are shown only where the filing and data support a comparison.
Original Japanese label
- Surgical products
- サージカル関連製品
- Iris needle products
- アイレス針関連製品
- Dental products
- デンタル関連製品
- Sales
- 売上高
- Operating profit
- 営業利益
Original Japanese label
- Surgical products
- サージカル関連製品
- Iris needle products
- アイレス針関連製品
- Dental products
- デンタル関連製品
- Sales
- 売上高
- Operating profit
- 営業利益
Reported Sales by business over time
Reported Sales by business over time
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Surgical products | ¥4.88B | ¥5.96B | ¥6.78B | ¥8.15B | ¥9.27B |
| Iris needle products | ¥5.05B | ¥6.25B | ¥8.58B | ¥10.22B | ¥11.18B |
| Dental products | ¥7.26B | ¥8.21B | ¥9.13B | ¥10.14B | ¥9.51B |
All amounts are in Japanese yen (JPY). Each figure links to the original Japanese filing. Blank cells indicate no comparable figure was disclosed. Business figures may not add up to consolidated figures.
What is growing?
What is growing?
Business revenue growth
Iris needle products
Reported revenue in 2020 ¥5.05B Reported revenue in 2024 ¥11.18B
- growth amount
- +¥6.14B
- growth annualized
- +22.0%
- growth total
- +121.6%
View original filing
Surgical products
Reported revenue in 2020 ¥4.88B Reported revenue in 2024 ¥9.27B
- growth amount
- +¥4.39B
- growth annualized
- +17.4%
- growth total
- +90.0%
View original filing
Dental products
Reported revenue in 2020 ¥7.26B Reported revenue in 2023 ¥10.14B
- growth amount
- +¥2.88B
- growth annualized
- +11.8%
- growth total
- +39.6%
View original filing
Iris needle products
Reported profit margin in 2021 +28.0%
Reported profit margin in 2024 +35.8%
- growth margin points
- +7.8
View original filing
This describes a reported period; it is not a forecast.
What has changed?
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
Public filing
FY2024 · fiscal year ended August 2025
The source document may be in Japanese.
Filing ID: S100X59Q
View original filing ↗Ask about this company
Ask about this company
The source document may be in Japanese.